INIS
lipids
100%
cholesterol
100%
patients
83%
therapy
83%
blood flow
66%
vasodilatation
66%
serotonin
50%
control
33%
density
33%
elevation
33%
lipoproteins
33%
levels
16%
reduction
16%
hypertension
16%
tissues
16%
mortality
16%
comparative evaluations
16%
netherlands
16%
clinical trials
16%
hospitals
16%
units
16%
endothelium
16%
universities
16%
nitric oxide
16%
Keyphrases
Cholesterol
100%
Familial Combined Hyperlipidemia
100%
Lipid-lowering Therapy
57%
Vasodilatation
57%
Forearm Blood Flow
57%
Serotonin
42%
LDL Cholesterol
42%
Forearm
28%
Intermediate-density Lipoprotein
28%
Netherlands
14%
Clinical Trials
14%
Endothelium
14%
Hypertension
14%
Controlled Experiment
14%
Cardiovascular Mortality
14%
Lipid Fractions
14%
Nitric Oxide
14%
University Hospital
14%
Flow Response
14%
Endothelial Function
14%
Anti-atherosclerosis
14%
Nephrology
14%
Utrecht
14%
Venous Occlusion Plethysmography
14%
Absolute Reductions
14%
Publication Type
14%
Flow Unit
14%
Lp(a)
14%
NO Release
14%
Lipid-lowering Medications
14%
Pharmacology, Toxicology and Pharmaceutical Science
Familial Hyperlipemia
100%
Serotonin
42%
Low Density Lipoprotein Cholesterol
28%
Intermediate Density Lipoprotein
28%
Nitric Oxide
14%
Normal Human
14%
Vein Occlusion
14%
Clinical Trial
14%
Very Low Density Lipoprotein
14%
Cardiovascular Mortality
14%
Immunology and Microbiology
Vasodilatation
100%
Forearm Blood Flow
100%
Normal Human
25%
Cardiovascular Mortality
25%
Biochemistry, Genetics and Molecular Biology
Intermediate-Density Lipoprotein
28%